{"id":1922,"date":"2015-12-29T05:56:40","date_gmt":"2015-12-29T05:56:40","guid":{"rendered":"http:\/\/alaskahemp.com\/420\/?p=1922"},"modified":"2015-12-29T05:56:40","modified_gmt":"2015-12-29T05:56:40","slug":"possible-antiproliferative-action-on-tumor-cells-reported","status":"publish","type":"post","link":"http:\/\/alaskahemp.com\/420\/possible-antiproliferative-action-on-tumor-cells-reported\/","title":{"rendered":"Possible antiproliferative action on tumor cells reported"},"content":{"rendered":"\n

Here we report the first clinical study aimed at assessing cannabinoid antitumoral action, specifically a pilot phase I trial in which nine patients with recurrent glioblastoma multiforme were administered THC intratumoraly.<\/p><\/blockquote>\n

\"\"<\/a><\/p>\n

 <\/p>\n

British Journal of Cancer<\/i> (2006) 95<\/b>, 197\u2013203. doi:10.1038\/sj.bjc.6603236 www.bjcancer.com<\/a>
\nPublished online 27\u00a0June\u00a02006<\/p>\n

A pilot clinical study of \u03949<\/sup>-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme<\/h2>\n

M\u00a0Guzm\u00e1n1<\/a><\/sup>, M J\u00a0Duarte2<\/a><\/sup>, C\u00a0Bl\u00e1zquez1<\/a><\/sup>, J\u00a0Ravina2<\/a><\/sup>, M C\u00a0Rosa2<\/a><\/sup>, I\u00a0Galve-Roperh1<\/a><\/sup>, C\u00a0S\u00e1nchez1<\/a><\/sup>, G\u00a0Velasco1<\/a><\/sup> and L\u00a0Gonz\u00e1lez-Feria2<\/a><\/sup><\/p>\n

\n
    \n
  1. 1<\/sup>Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid 28040, Spain<\/li>\n
  2. 2<\/sup>Department of Neurosurgery, Hospital Universitario de Canarias, La Laguna, Tenerife 38320, Spain<\/li>\n<\/ol>\n

    Correspondence: Professor M Guzm\u00e1n, E-mail: mgp@bbm1.ucm.es<\/a>; Professor L Gonz\u00e1lez-Feria, E-mail: lgferia@yahoo.es<\/a><\/p>\n

    http:\/\/www.nature.com\/bjc\/journal\/v95\/n2\/abs\/6603236a.html<\/a><\/strong><\/p>\n<\/div>\n

     <\/p>\n","protected":false},"excerpt":{"rendered":"

    Here we report the first clinical study aimed at assessing cannabinoid antitumoral action, specifically a pilot phase I trial in which nine patients with recurrent glioblastoma multiforme were administered THC intratumoraly.   British Journal of Cancer (2006) 95, 197\u2013203. doi:10.1038\/sj.bjc.6603236 www.bjcancer.com Published online 27\u00a0June\u00a02006 A pilot clinical study of \u03949-tetrahydrocannabinol in patients with recurrent glioblastoma […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,7],"tags":[166,60,168,167],"class_list":["post-1922","post","type-post","status-publish","format-standard","hentry","category-cancer","category-medijuana","tag-cancer","tag-cannabis","tag-glioblastoma","tag-rso"],"_links":{"self":[{"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/posts\/1922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/comments?post=1922"}],"version-history":[{"count":1,"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/posts\/1922\/revisions"}],"predecessor-version":[{"id":1923,"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/posts\/1922\/revisions\/1923"}],"wp:attachment":[{"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/media?parent=1922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/categories?post=1922"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/alaskahemp.com\/420\/wp-json\/wp\/v2\/tags?post=1922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}